In most cases of acromegaly, this excessive growth hormone production stems from a noncancerous tumor in the pituitary gland. However, in rarer instances, the disease can be triggered by tumors ...

Stifel initiates coverage on CRNX, a clinical-stage pharmaceutical company focused on endocrine diseases and tumors.

The novel consensus statement highlights current analytical pitfalls and the need to optimize disease control in acromegaly. Acromegaly is a serious endocrine disease associated with increased ...

George Moanaroa believes the spiritual world of Te Ao Māori and the medical world joined forces to save his life. Moanaroa ...

MAR002 holds promise as a first-in-class treatment for acromegaly, a life-shortening disease often with serious complications. We appreciate ProBioGen's support throughout the process and look forward ...

Acromegaly is due to hypersecretion of growth ... Medical treatment of the disease is usually with somatostatin analogs. An open, prospective, single-center study by Maiza et al.